Add like
Add dislike
Add to saved papers

Control of Selectivity through Synergy between Catalysts, Silanes and Reaction Conditions in Cobalt-Catalyzed Hydrosilylation of Dienes and Terminal Alkenes.

ACS Catalysis 2017 April 8
Readily accessible ( (i)(-Pr)PDI)CoCl2 [ (i)(-Pr) PDI = 2,6-bis(2,6-diisopropylphenyliminoethyl)pyridine] reacts with 2 equivalents of NaEt3BH at -78 °C in toluene to generate a catalyst that effects highly selective anti-Markovnikov hydrosilylation of the terminal double bond in 1,3- and 1,4-dienes. Primary and secondary silanes such as PhSiH3, Ph2SiH2 and PhSi(Me)H2 react with a broad spectrum of terminal dienes without affecting the configuration of the other double bond. When dienes conjugated to an aromatic ring are involved, both Markovnikov and anti-Markovnikov products are formed. The reaction is tolerant of various functional groups such as an aryl bromide, aryl iodide, protected alcohol, and even a silyl enol ether. Reactions of 1-alkene under similar conditions cleanly lead to a mixture of Markovnikov and anti-Markovnikov hydrosilation products, where ratio of the products increasingly favors the latter, as the size of the 2,6-substituents in the iminoylaryl group becomes larger. The complex ( (i)(-Pr)PDI)CoCl2 gives exclusively the linear silane for a wide variety of terminal alkenes. Mechanistic studies suggest a pathway that involves a key role for an in situ generated metal hydride, (L)Co(I)-H. Exclusive reduction of the terminal double bond (vis-a-vis hydrosilylation) when (EtO)2Si(Me)H is used in the place of PhSiH3 is explained on the basis of an alternate silane-mediated decomposition path for the linear Co(I)-alkyl intermediate.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app